Your browser doesn't support javascript.
loading
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.
Lieberman, Lani; Lopriore, Enrico; Baker, Jillian M; Bercovitz, Rachel S; Christensen, Robert D; Crighton, Gemma; Delaney, Meghan; Goel, Ruchika; Hendrickson, Jeanne E; Keir, Amy; Landry, Denise; La Rocca, Ursula; Lemyre, Brigitte; Maier, Rolf F; Muniz-Diaz, Eduardo; Nahirniak, Susan; New, Helen V; Pavenski, Katerina; Dos Santos, Maria Cristina Pessoa; Ramsey, Glenn; Shehata, Nadine.
Afiliação
  • Lieberman L; Department of Clinical Pathology, University Health Network, Toronto, Ontario, Canada.
  • Lopriore E; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Baker JM; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Bercovitz RS; Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Christensen RD; Department of Pediatrics, Unity Health Toronto (St. Michael's Hospital), Toronto, Ontario, Canada.
  • Crighton G; Division of Haematology-Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Delaney M; Division of Hematology, Oncology, and Stem Cell Transplant, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Goel R; Divisions of Neonatology and Hematology/Oncology, University of Utah Health, Salt Lake City, UT, USA.
  • Hendrickson JE; Department of Women and Newborn's Research, Intermountain Healthcare, Salt Lake City, Utah, USA.
  • Keir A; Department of Haematology, Royal Children's Hospital, Melbourne, Australia.
  • Landry D; Division of Pathology & Laboratory Medicine, Children's National Hospital, Washington, District of Columbia, USA.
  • La Rocca U; Department of Pathology & Pediatrics, The George Washington University Health Sciences, Washington, District of Columbia, USA.
  • Lemyre B; Division of Transfusion Medicine, Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Maier RF; Simmons Cancer Institute at SIU School of Medicine, Springfield, Illinois, USA.
  • Muniz-Diaz E; Departments of Laboratory Medicine and Pediatrics, Yale University, New Haven, Connecticut, USA.
  • Nahirniak S; SAHMRI Women and Kids, South Australian Health and Medical Institute, North Adelaide, South Australia, Australia.
  • New HV; Adelaide Medical School and the Robinson Research Institute, the University of Adelaide, North Adelaide, South Australia, Australia.
  • Pavenski K; Canadian Blood Services, Ottawa, Ontario, Canada.
  • Dos Santos MCP; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Ramsey G; Italian National Blood Centre, National Institute of Health, Rome, Italy.
  • Shehata N; Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.
Br J Haematol ; 198(1): 183-195, 2022 07.
Article em En | MEDLINE | ID: mdl-35415922
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Eritroblastose Fetal Tipo de estudo: Guideline / Systematic_reviews Limite: Female / Humans / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Eritroblastose Fetal Tipo de estudo: Guideline / Systematic_reviews Limite: Female / Humans / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article